---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-137744"
form_type: "8-K"
ticker: "KRYS"
cik: "0001711279"
company_name: "Krystal Biotech, Inc."
filed_at: "2023-05-08T23:59:59+00:00"
generated_at: "2026-06-15T13:44:48.339164+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Krystal Biotech enters $150M ATM equity offering with Cowen

## Summary
- Sales agreement with Cowen for at-the-market offering of up to $150M common stock.
- Cowen receives 3.0% commission on gross proceeds from each sale; no obligation to sell.
- Shares offered under existing shelf registration; proceeds for general corporate purposes.
- Either party may suspend or terminate the offering with notice.

## SEC filing metadata
- accession: 0001193125-23-137744
- form_type: 8-K
- ticker: KRYS
- cik: 0001711279
- company_name: Krystal Biotech, Inc.
- filed_at: 2023-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711279/000119312523137744/0001193125-23-137744-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711279/000119312523137744/d431837d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-137744
- JSON: https://secwatch.observer/filing/0001193125-23-137744.json
- Plain text: https://secwatch.observer/filing/0001193125-23-137744.txt

## Key facts
- Material Agreements
  Krystal Biotech, Inc. entered into Sales Agreement with Cowen and Company, LLC valued at up to $150.0 million (effective 2023-05-08).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Cowen and Company, LLC
  - Value: up to $150.0 million
  - Effective: 2023-05-08
  source text: On May 8, 2023, Krystal Biotech, Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Cowen and Company, LLC (“Cowen”) to issue and sell shares of the Company’s common stock, par value $0.00001 per share, having an aggregate offering price of up to $150.0 million (the “Placement Shares”) from time to time during the term of the Sales Agreement, through an “at-the-market” equity offering program under which Cowen will act as the Company’s agent and/or principal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1711279/000119312523137744/0001193125-23-137744-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.